| Literature DB >> 15925109 |
Ignacio F Mata1, Julie P Taylor, Jennifer Kachergus, Mary Hulihan, Cecilia Huerta, Carlos Lahoz, Marta Blazquez, Luis M Guisasola, Carlos Salvador, Renee Ribacoba, Carmen Martinez, Matthew Farrer, Victoria Alvarez.
Abstract
Pathogenic mutations in leucine-rich repeat kinase 2 (LRRK2; PARK8) have been implicated in autosomal dominant, late-onset Parkinson's disease (PD). The LRRK2 4321C>G (R1441G) mutation was originally identified in Spanish families originating from the Basque region. Within this ethnicity, Lrrk2 R1441G substitutions have been suggested as a frequent cause of disease. Herein we have assessed another referral-based series of 225 patients with PD from the neighboring region of Asturias, Northern Spain. The LRRK2 4321C>G mutation was found in 5 (2.7%) of sporadic, late-onset patients and was not present in control subjects. Although patients with a Lrrk2 R1441G substitution are apparently unrelated, they share a chromosome 12q12 haplotype not found in controls and indicative of a common founder.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15925109 DOI: 10.1016/j.neulet.2005.03.033
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046